STUDY OBJECTIVE: To test the effects of coffee and napping on nocturnal driving in young and middle-aged participants. DESIGN: A cup of coffee (200 mg of caffeine), a placebo (decaffeinated coffee, 15 mg of caffeine), or a 30-minute nap were tested. Participants drove 125 highway miles between 18:00 and 19:30 and between 02:00 and 03:30 after coffee, placebo, or a nap. SETTING: Sleep laboratory and open French highway. PARTICIPANTS: Twelve young (range, 20-25 years) and 12 middle-aged participants (range, 40-50 years). MEASUREMENTS: Inappropriate line crossings, self-perceived fatigue and sleepiness, and polysomnographic recordings were analyzed. RESULTS: Compared to daytime, after placebo the number of inappropriate line crossings was significantly increased (2 versus 73 for young participants, P < 0.01 and 0 versus 76 for the middle-aged participants, P < 0.05). Both coffee and napping reduced the risk of inappropriate line crossings, compared with placebo, in young participants (respectively, by three-quarters, incidence rate ratios [IRR] = 0.26 95% confidence interval [CI], 0.09-0.74, P < 0.05 and by two thirds, IRR = 0.34 95% CI, 0.20-0.58, P < 0.001) and in middle-aged participants (respectively by nine tenths, IRR = 0.11 95% CI, 0.05-0.21, P < 0.001 and by one fifth, IRR = 0.77 95% CI, 0.63-0.95, P < 0.05). A significant interaction between age and condition (IRR = 2.27 95% CI, 1.28-4.16 P < 0.01) showed that napping led to fewer inappropriate line crossings in younger participants than in middle-aged participants. During napping, young participants slept more (P < 0.01) and had more delta sleep (P < 0.05) than middle-aged participants. Self-perceived sleepiness and fatigue did not differ in both age groups, but coffee improved sleepiness (P < 0.05), whereas napping did not. CONCLUSIONS: Coffee significantly improves performance in young and middle-aged participants. Napping is more efficient in younger than in older participants. Countermeasures to sleepiness should be adapted according to the age of drivers.
RCT Entities:
STUDY OBJECTIVE: To test the effects of coffee and napping on nocturnal driving in young and middle-aged participants. DESIGN: A cup of coffee (200 mg of caffeine), a placebo (decaffeinated coffee, 15 mg of caffeine), or a 30-minute nap were tested. Participants drove 125 highway miles between 18:00 and 19:30 and between 02:00 and 03:30 after coffee, placebo, or a nap. SETTING: Sleep laboratory and open French highway. PARTICIPANTS: Twelve young (range, 20-25 years) and 12 middle-aged participants (range, 40-50 years). MEASUREMENTS: Inappropriate line crossings, self-perceived fatigue and sleepiness, and polysomnographic recordings were analyzed. RESULTS: Compared to daytime, after placebo the number of inappropriate line crossings was significantly increased (2 versus 73 for young participants, P < 0.01 and 0 versus 76 for the middle-aged participants, P < 0.05). Both coffee and napping reduced the risk of inappropriate line crossings, compared with placebo, in young participants (respectively, by three-quarters, incidence rate ratios [IRR] = 0.26 95% confidence interval [CI], 0.09-0.74, P < 0.05 and by two thirds, IRR = 0.34 95% CI, 0.20-0.58, P < 0.001) and in middle-aged participants (respectively by nine tenths, IRR = 0.11 95% CI, 0.05-0.21, P < 0.001 and by one fifth, IRR = 0.77 95% CI, 0.63-0.95, P < 0.05). A significant interaction between age and condition (IRR = 2.27 95% CI, 1.28-4.16 P < 0.01) showed that napping led to fewer inappropriate line crossings in younger participants than in middle-aged participants. During napping, young participants slept more (P < 0.01) and had more delta sleep (P < 0.05) than middle-aged participants. Self-perceived sleepiness and fatigue did not differ in both age groups, but coffee improved sleepiness (P < 0.05), whereas napping did not. CONCLUSIONS: Coffee significantly improves performance in young and middle-aged participants. Napping is more efficient in younger than in older participants. Countermeasures to sleepiness should be adapted according to the age of drivers.
Authors: T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda Journal: Psychiatry Clin Neurosci Date: 2001-06 Impact factor: 5.188
Authors: Laura K Barger; Brian E Cade; Najib T Ayas; John W Cronin; Bernard Rosner; Frank E Speizer; Charles A Czeisler Journal: N Engl J Med Date: 2005-01-13 Impact factor: 91.245
Authors: Montserrat Sanchez-Ortuno; Nicholas Moore; Jacques Taillard; Cédric Valtat; Damien Leger; Bernard Bioulac; Pierre Philip Journal: Sleep Med Date: 2005-01-24 Impact factor: 3.492
Authors: Pierre Philip; Jacques Taillard; Patricia Sagaspe; Cédric Valtat; Montserrat Sanchez-Ortuno; Nicholas Moore; André Charles; Bernard Bioulac Journal: J Sleep Res Date: 2004-06 Impact factor: 3.981
Authors: Marco Túlio de Mello; Fernanda Veruska Narciso; Sergio Tufik; Teresa Paiva; David Warren Spence; Ahmed S Bahammam; Joris C Verster; Seithikurippu R Pandi-Perumal Journal: Int J Prev Med Date: 2013-03
Authors: Jacques Taillard; Aurore Capelli; Patricia Sagaspe; Anna Anund; Torbjorn Akerstedt; Pierre Philip Journal: PLoS One Date: 2012-10-19 Impact factor: 3.240